https://www.selleckchem.com/pr....oducts/PD-0325901.ht
These results are consistent with the idea that SCZ use a different strategy while they perform the DRM paradigm. © 2020 The Authors.Objective To assess cognitive functioning in adolescents (12-17 years old) with schizophrenia during open-label treatment with paliperidone extended-release (pali ER). Methods In this exploratory analysis, adolescents treated with pali ER (oral, flexibly dosed, 1.5-12 mg/day) underwent cognitive assessments at baseline and month 6 using a battery of cognitive tests validated in adolescents. Correlation
Like
Comment
Share
